4r9h - Revision history

OCA at 17:46, 20 September 2023

OCA — Wed, 20 Sep 2023 17:46:06 GMT

←Older revision		Revision as of 17:46, 20 September 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4r9h]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R9H OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4R9H FirstGlance]. <br>		<table><tr><td colspan='2'>[[4r9h]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R9H OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4R9H FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4r9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r9h OCA], [https://pdbe.org/4r9h PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4r9h RCSB], [https://www.ebi.ac.uk/pdbsum/4r9h PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4r9h ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.9Å</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4r9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r9h OCA], [https://pdbe.org/4r9h PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4r9h RCSB], [https://www.ebi.ac.uk/pdbsum/4r9h PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4r9h ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==

OCA at 06:46, 2 March 2023

OCA — Thu, 02 Mar 2023 06:46:21 GMT

←Older revision		Revision as of 06:46, 2 March 2023
Line 1:		Line 1:

	==Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution==		==Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution==
-	<StructureSection load='4r9h' size='340' side='right' caption='[[4r9h]], [[Resolution\|resolution]] 1.90Å' scene=''>	+	<StructureSection load='4r9h' size='340' side='right'caption='[[4r9h]], [[Resolution\|resolution]] 1.90Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4r9h]] is a 4 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R9H OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4R9H FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4r9h]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R9H OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4R9H FirstGlance]. <br>
-	</td></tr>~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4ra3\|4ra3]], [[4rah\|4rah]]</td></tr>~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4r9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r9h OCA], [https://pdbe.org/4r9h PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4r9h RCSB], [https://www.ebi.ac.uk/pdbsum/4r9h PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4r9h ProSAT]</span></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">B2M, CDABP0092, HDCMA22P, NM_004048 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4r9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r9h OCA], [~~http~~://pdbe.org/4r9h PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4r9h RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4r9h PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4r9h ProSAT]</span></td></tr>	+
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Defects in B2M are the cause of hypercatabolic hypoproteinemia (HYCATHYP) [MIM:[~~http~~://omim.org/entry/241600 241600]]. Affected individuals show marked reduction in serum concentrations of immunoglobulin and albumin, probably due to rapid degradation.<ref>PMID:16549777</ref> Note=Beta-2-microglobulin may adopt the fibrillar configuration of amyloid in certain pathologic states. The capacity to assemble into amyloid fibrils is concentration dependent. Persistently high beta(2)-microglobulin serum levels lead to amyloidosis in patients on long-term hemodialysis.<ref>PMID:3532124</ref> <ref>PMID:1336137</ref> <ref>PMID:7554280</ref> <ref>PMID:4586824</ref> <ref>PMID:8084451</ref> <ref>PMID:12119416</ref> <ref>PMID:12796775</ref> <ref>PMID:16901902</ref> <ref>PMID:16491088</ref> <ref>PMID:17646174</ref> <ref>PMID:18835253</ref> <ref>PMID:18395224</ref> <ref>PMID:19284997</ref>	+	[https://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN] Defects in B2M are the cause of hypercatabolic hypoproteinemia (HYCATHYP) [MIM:[https://omim.org/entry/241600 241600]. Affected individuals show marked reduction in serum concentrations of immunoglobulin and albumin, probably due to rapid degradation.<ref>PMID:16549777</ref> Note=Beta-2-microglobulin may adopt the fibrillar configuration of amyloid in certain pathologic states. The capacity to assemble into amyloid fibrils is concentration dependent. Persistently high beta(2)-microglobulin serum levels lead to amyloidosis in patients on long-term hemodialysis.<ref>PMID:3532124</ref> <ref>PMID:1336137</ref> <ref>PMID:7554280</ref> <ref>PMID:4586824</ref> <ref>PMID:8084451</ref> <ref>PMID:12119416</ref> <ref>PMID:12796775</ref> <ref>PMID:16901902</ref> <ref>PMID:16491088</ref> <ref>PMID:17646174</ref> <ref>PMID:18835253</ref> <ref>PMID:18395224</ref> <ref>PMID:19284997</ref>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system.	+	[https://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system.
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 23:		Line 21:

	==See Also==		==See Also==
-	*[[Beta-2 microglobulin\|Beta-2 microglobulin]]	+	*[[Beta-2 microglobulin 3D structures\|Beta-2 microglobulin 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
-	[[Category: ~~Bolognesi, M~~]]	+	[[Category: Large Structures]]
-	[[Category: ~~Halabelian, L~~]]	+	[[Category: Bolognesi M]]
-	[[Category: ~~Ricagno, S~~]]	+	[[Category: Halabelian L]]
-	[[Category: ~~Amyloidosis]]~~	+	[[Category: Ricagno S]]
-	~~[[Category: Beta sandwich]]~~	+
-	~~[[Category: Covalent dimer]]~~	+
-	~~[[Category: Immune system]]~~	+
-	~~[[Category: Inclusion body]]~~	+
-	~~[[Category: Oligomerization]]~~	+
-	~~[[Category: Protein aggregation~~]]	+

OCA at 05:46, 27 June 2018

OCA — Wed, 27 Jun 2018 05:46:14 GMT

←Older revision		Revision as of 05:46, 27 June 2018
Line 21:		Line 21:
	</div>		</div>
	<div class="pdbe-citations 4r9h" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 4r9h" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Beta-2 microglobulin\|Beta-2 microglobulin]]
	== References ==		== References ==
	<references/>		<references/>

OCA at 16:08, 16 November 2017

OCA — Thu, 16 Nov 2017 16:08:01 GMT

←Older revision		Revision as of 16:08, 16 November 2017
Line 1:		Line 1:
		+
	==Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution==		==Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution==
	<StructureSection load='4r9h' size='340' side='right' caption='[[4r9h]], [[Resolution\|resolution]] 1.90Å' scene=''>		<StructureSection load='4r9h' size='340' side='right' caption='[[4r9h]], [[Resolution\|resolution]] 1.90Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4r9h]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R9H OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4R9H FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4r9h]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R9H OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4R9H FirstGlance]. <br>
	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4ra3\|4ra3]], [[4rah\|4rah]]</td></tr>		</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4ra3\|4ra3]], [[4rah\|4rah]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4r9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r9h OCA], [http://pdbe.org/4r9h PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4r9h RCSB], [http://www.ebi.ac.uk/pdbsum/4r9h PDBsum]</span></td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">B2M, CDABP0092, HDCMA22P, NM_004048 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4r9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r9h OCA], [http://pdbe.org/4r9h PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4r9h RCSB], [http://www.ebi.ac.uk/pdbsum/4r9h PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4r9h ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 23:		Line 25:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Bolognesi, M]]		[[Category: Bolognesi, M]]
	[[Category: Halabelian, L]]		[[Category: Halabelian, L]]

OCA at 21:47, 30 November 2015

OCA — Mon, 30 Nov 2015 21:47:44 GMT

←Older revision		Revision as of 21:47, 30 November 2015
Line 10:		Line 10:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system.		[[http://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system.
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Early oligomers are crucial in amyloid aggregation; however, due to their transient nature they are among the least structurally characterized species. We focused on the amyloidogenic protein beta2-microglobulin (beta2m) whose early oligomers are still a matter of debate. An intermolecular interaction between D strands of facing beta2m molecules was repeatedly observed, suggesting that such interface may be relevant for beta2m dimerization. In this study, by mutating Ser33 to Cys, and assembling the disulphide-stabilized beta2m homodimer (DimC33), such DD strand interface was locked. Although the isolated DimC33 display a stability similar to wt beta2m under native conditions, it shows enhanced amyloid aggregation propensity. Three distinct crystal structures of DimC33 suggest that dimerization through the DD interface is instrumental for enhancing DimC33 aggregation propensity. Furthermore, the crystal structure of DimC33 in complex with the amyloid-specific dye Thioflavin-T pinpoints a second interface, which likely participates in the first steps of beta2m aggregation. The present data provide new insight into beta2m early steps of amyloid aggregation.
		+
		+	A covalent homodimer probing early oligomers along amyloid aggregation.,Halabelian L, Relini A, Barbiroli A, Penco A, Bolognesi M, Ricagno S Sci Rep. 2015 Sep 30;5:14651. doi: 10.1038/srep14651. PMID:26420657<ref>PMID:26420657</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 4r9h" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 08:04, 30 September 2015

OCA — Wed, 30 Sep 2015 08:04:27 GMT

←Older revision		Revision as of 08:04, 30 September 2015
Line 4:		Line 4:
	<table><tr><td colspan='2'>[[4r9h]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R9H OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4R9H FirstGlance]. <br>		<table><tr><td colspan='2'>[[4r9h]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R9H OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4R9H FirstGlance]. <br>
	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4ra3\|4ra3]], [[4rah\|4rah]]</td></tr>		</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4ra3\|4ra3]], [[4rah\|4rah]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4r9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r9h OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4r9h RCSB], [http://www.ebi.ac.uk/pdbsum/4r9h PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4r9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r9h OCA], [http://pdbe.org/4r9h PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4r9h RCSB], [http://www.ebi.ac.uk/pdbsum/4r9h PDBsum]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==

OCA at 11:17, 9 September 2015

OCA — Wed, 09 Sep 2015 11:17:39 GMT

←Older revision		Revision as of 11:17, 9 September 2015
Line 1:		Line 1:
-	'''~~Unreleased structure~~'''	+	==Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution==
-		+	<StructureSection load='4r9h' size='340' side='right' caption='[[4r9h]], [[Resolution\|resolution]] 1.90Å' scene=''>
-	~~The entry~~ 4r9h is ~~ON HOLD until Paper Publication~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[4r9h]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R9H OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4R9H FirstGlance]. <br>
-	~~Authors~~: ~~Halabelian~~, L., ~~Bolognesi, M~~., ~~Ricagno, S~~.	+	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4ra3\|4ra3]], [[4rah\|4rah]]</td></tr>
-		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4r9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r9h OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4r9h RCSB], [http://www.ebi.ac.uk/pdbsum/4r9h PDBsum]</span></td></tr>
-	~~Description~~: ~~Crystal structure~~ of ~~dimeric S33C beta~~-2 microglobulin ~~mutant at 1~~.~~9 Angstrom resolution~~	+	</table>
-	[[Category: ~~Unreleased Structures~~]]	+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Defects in B2M are the cause of hypercatabolic hypoproteinemia (HYCATHYP) [MIM:[http://omim.org/entry/241600 241600]]. Affected individuals show marked reduction in serum concentrations of immunoglobulin and albumin, probably due to rapid degradation.<ref>PMID:16549777</ref> Note=Beta-2-microglobulin may adopt the fibrillar configuration of amyloid in certain pathologic states. The capacity to assemble into amyloid fibrils is concentration dependent. Persistently high beta(2)-microglobulin serum levels lead to amyloidosis in patients on long-term hemodialysis.<ref>PMID:3532124</ref> <ref>PMID:1336137</ref> <ref>PMID:7554280</ref> <ref>PMID:4586824</ref> <ref>PMID:8084451</ref> <ref>PMID:12119416</ref> <ref>PMID:12796775</ref> <ref>PMID:16901902</ref> <ref>PMID:16491088</ref> <ref>PMID:17646174</ref> <ref>PMID:18835253</ref> <ref>PMID:18395224</ref> <ref>PMID:19284997</ref>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system.
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Bolognesi, M]]
	[[Category: Halabelian, L]]		[[Category: Halabelian, L]]
	[[Category: Ricagno, S]]		[[Category: Ricagno, S]]
-	[[Category: ~~Bolognesi, M~~]]	+	[[Category: Amyloidosis]]
		+	[[Category: Beta sandwich]]
		+	[[Category: Covalent dimer]]
		+	[[Category: Immune system]]
		+	[[Category: Inclusion body]]
		+	[[Category: Oligomerization]]
		+	[[Category: Protein aggregation]]

OCA at 16:39, 24 December 2014

OCA — Wed, 24 Dec 2014 16:39:19 GMT

←Older revision		Revision as of 16:39, 24 December 2014
Line 6:		Line 6:

	Description: Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution		Description: Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution
		+	[[Category: Unreleased Structures]]
		+	[[Category: Halabelian, L]]
		+	[[Category: Ricagno, S]]
		+	[[Category: Bolognesi, M]]

OCA at 23:07, 1 October 2014

OCA — Wed, 01 Oct 2014 23:07:27 GMT

←Older revision		Revision as of 23:07, 1 October 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4r9h is ON HOLD	+	The entry 4r9h is ON HOLD until Paper Publication

	Authors: Halabelian, L., Bolognesi, M., Ricagno, S.		Authors: Halabelian, L., Bolognesi, M., Ricagno, S.

	Description: Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution		Description: Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution

OCA: Protected "4r9h" [edit=sysop:move=sysop]

OCA — Wed, 24 Sep 2014 08:26:59 GMT

Protected "4r9h" [edit=sysop:move=sysop]

←Older revision

Revision as of 08:26, 24 September 2014